The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Scheffer, R. E.
* Articles by Rush, A. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Scheffer, R. E.
* Articles by Rush, A. J.
Related Collections
* Attention Deficit Hyperactivity Disorder
* Other Childhood Disorders
* Anticonvulsants
* Other Somatic Therapy
Am J Psychiatry 162:58-64, January 2005
© 2005 American Psychiatric Association

Randomized, Placebo-Controlled Trial of Mixed Amphetamine Salts for Symptoms of Comorbid ADHD in Pediatric Bipolar Disorder After Mood Stabilization With Divalproex Sodium

Russell E. Scheffer, M.D., Robert A. Kowatch, M.D., Thomas Carmody, Ph.D., and A. John Rush, M.D.

OBJECTIVE: The purpose of this study was to determine whether adjunctive use of a psychostimulant (mixed amphetamine salts) was safe and efficacious for treatment of symptoms of attention deficit hyperactivity disorder (ADHD) in pediatric outpatients with bipolar I or bipolar II disorder and concurrent ADHD whose manic symptoms had been stabilized through treatment with divalproex sodium. METHOD: An 8-week open-label trial of divalproex sodium to control manic symptoms and to discern the effect of divalproex sodium on ADHD was followed by a 4-week randomized, double-blind, placebo-controlled crossover trial to determine if mixed amphetamine salts was safe and effective for treatment of ADHD symptoms. Patients in the crossover trial continued to receive divalproex sodium. Diagnoses, made by clinical interview, were confirmed with the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia. The Young Mania Rating Scale (for manic symptoms) and the Clinical Global Impression of improvement (for ADHD symptoms) were the primary outcome measures. RESULTS: Forty subjects ages 6–17 years with bipolar I disorder (77.5%) or bipolar II disorder (22.5%) and a Young Mania Rating Scale score ≥14 entered open treatment with divalproex sodium. With divalproex sodium, 32 subjects achieved ≥50% reduction in Young Mania Rating Scale baseline scores, but only three participants had significant improvement in ADHD symptoms. For the 30 subjects who entered the placebo-controlled crossover trial, mixed amphetamine salts was significantly more effective than placebo for ADHD symptoms. No significant side effects or worsening of manic symptoms was observed. CONCLUSIONS: Pediatric patients with bipolar disorder and concurrent ADHD can be safely and effectively treated with mixed amphetamine salts after their manic symptoms are stabilized with divalproex sodium. Divalproex sodium alone (8-week trial) is not an effective treatment for ADHD in the context of bipolar disorder.




This article has been cited by other articles:


Home page
PediatricsHome page
J. Biederman, M. C. Monuteaux, T. Spencer, T. E. Wilens, and S. V. Faraone
Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
Pediatrics, July 1, 2009; 124(1): 71 - 78.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. A. Carlson
Treating the Childhood Bipolar Controversy: A Tale of Two Children
Am J Psychiatry, January 1, 2009; 166(1): 18 - 24.
[Full Text] [PDF]


Home page
FocusHome page
S. E. Meyer and G. A. Carlson
Early-Onset Bipolar Disorder
Focus, June 1, 2008; 6(3): 271 - 283.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
C. Moreno, G. Laje, C. Blanco, H. Jiang, A. B. Schmidt, and M. Olfson
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Arch Gen Psychiatry, September 1, 2007; 64(9): 1032 - 1039.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. D. Chang and D. Shah
The Bipolar Child: The Definitive and Reassuring Guide to Childhood's Most Misunderstood Disorder
JAMA, July 4, 2007; 298(1): 96 - 97.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
B. WASLICK
Oxcarbazepine and Pediatric Bipolar Disorder
Am J Psychiatry, December 1, 2006; 163(12): 2195 - 2195.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. P. KRUSZEWSKI and R. PACZYNSKI
Conclusions Inconsistent With Results With Amphetamines and Divalproex
Am J Psychiatry, November 1, 2005; 162(11): 2197 - 2197.
[Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
J. Wozniak
Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD
Evid. Based Ment. Health, August 1, 2005; 8(3): 78 - 78.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Stimulants and Stabilizers for ADHD and Bipolar Disorder
Journal Watch Psychiatry, February 24, 2005; 2005(224): 1 - 1.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org